EUDA Health Holdings Ltd
EUDAAnalytical Summary
EUDA Health Holdings Ltd faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.
14-Year Financial Trajectory
QuarterlyBullish Indicators
- Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
Bearish Risks
- Operating Margin (%)Operating Margin (%) is in the bottom quartile
- Profit Margin (%)Profit Margin (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q4 FY2025 Dec 31, 2025 20-F ↗ | Q4 FY2024 Dec 31, 2024 20-F ↗ | Q1 FY2024 Dec 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 20-F ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 20-F ↗ | Q3 FY2022 Oct 31, 2022 10-Q ↗ | Q2 FY2022 Jul 31, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Oct 31, 2021 10-Q ↗ | Q2 FY2021 Jan 31, 2022 10-Q ↗ | Q1 FY2021 Oct 31, 2021 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue Growth YoY (%) | — | — |
2260.6%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+28157%)
|
— |
-36.3%
Weak
Weak
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Below avg (-554%)
|
— | — | — | — | — | — | — | — | — |
| FCF Growth YoY (%) | — | — | — | — |
14.6%
Fair
Fair
Year-over-year change in free cash flow |
— | — | — | — | — | — | — | — | — |
| Metric | Q4 FY2025 Dec 31, 2025 20-F ↗ | Q4 FY2024 Dec 31, 2024 20-F ↗ | Q1 FY2024 Dec 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 20-F ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 20-F ↗ | Q3 FY2022 Oct 31, 2022 10-Q ↗ | Q2 FY2022 Jul 31, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Oct 31, 2021 10-Q ↗ | Q2 FY2021 Jan 31, 2022 10-Q ↗ | Q1 FY2021 Oct 31, 2021 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin (%) (%) | — | — | — | — |
-116.4%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-876%)
|
— | — | — |
2.8%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-81%)
|
— | — | — | — | — |
| Effective Tax Rate (%) (%) | — | — | — | — |
-0.0%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— | — | — |
2.5%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— | — | — | — | — |
| Profit Margin (%) (%) | — | — | — | — |
-142.1%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-1285%)
|
— | — | — |
8.3%
Caution
Caution
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-30%)
|
— | — | — | — | — |
| FCF Margin (%) (%) | — | — | — | — |
-27.7%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— | — | — |
-9.5%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— | — | — | — | — |
| FCF / Net Income (x) | — | — | — | — |
0.19x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — |
-1.13x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — | — | — |
| Metric | Q4 FY2025 Dec 31, 2025 20-F ↗ | Q4 FY2024 Dec 31, 2024 20-F ↗ | Q1 FY2024 Dec 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 20-F ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 20-F ↗ | Q3 FY2022 Oct 31, 2022 10-Q ↗ | Q2 FY2022 Jul 31, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Oct 31, 2021 10-Q ↗ | Q2 FY2021 Jan 31, 2022 10-Q ↗ | Q1 FY2021 Oct 31, 2021 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Invested Capital (%) | — | — | — | — |
33.2%
Excellent
Excellent
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — | — | — | — | — |
-3.2%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— | — |
| Return on Capital (%) (%) | — | — | — | — |
-7.8%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — | — | — | — |
-0.3%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — |
| Return on Common Equity (%) (%) | — | — | — | — |
40.6%
Excellent
Excellent
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+170%)
|
— | — | — | — | — | — |
-4.1%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-127%)
|
— | — |
| Metric | Q4 FY2025 Dec 31, 2025 20-F ↗ | Q4 FY2024 Dec 31, 2024 20-F ↗ | Q1 FY2024 Dec 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 20-F ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 20-F ↗ | Q3 FY2022 Oct 31, 2022 10-Q ↗ | Q2 FY2022 Jul 31, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Oct 31, 2021 10-Q ↗ | Q2 FY2021 Jan 31, 2022 10-Q ↗ | Q1 FY2021 Oct 31, 2021 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Coverage (x) | — | — | — | — |
-324.59x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
— | — | — |
3.10x
Fair
Fair
Operating income divided by interest expense
Optimal:
> 5x
|
— | — | — | — | — |
| Net Debt (USD) | — | — | — | — | $-837.29K | $-57.54K | $-265.85K | $-193.55K | — | $-190.00K | — | — | — | — |
| Metric | Q4 FY2025 Dec 31, 2025 20-F ↗ | Q4 FY2024 Dec 31, 2024 20-F ↗ | Q1 FY2024 Dec 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 20-F ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 20-F ↗ | Q3 FY2022 Oct 31, 2022 10-Q ↗ | Q2 FY2022 Jul 31, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Oct 31, 2021 10-Q ↗ | Q2 FY2021 Jan 31, 2022 10-Q ↗ | Q1 FY2021 Oct 31, 2021 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Working Capital (USD) | $-4.80M | $-3.38M | — | $-7.99M | $-6.53M | $-4.09M | — | — | — | $-2.96M | — | — | — | — |
| Total Equity (USD) | $-4.25M | $-2.55M | — | $-7.50M | $-5.95M | $-3.52M | $-4.02M | $-3.72M | — | $521.23K | $-16.46K | $29.12K | — | — |
| Metric | Q4 FY2025 Dec 31, 2025 20-F ↗ | Q4 FY2024 Dec 31, 2024 20-F ↗ | Q1 FY2024 Dec 31, 2024 10-Q ↗ | Q4 FY2023 Dec 31, 2023 20-F ↗ | Q1 FY2023 Mar 31, 2023 10-Q ↗ | Q4 FY2022 Dec 31, 2022 20-F ↗ | Q3 FY2022 Oct 31, 2022 10-Q ↗ | Q2 FY2022 Jul 31, 2022 10-Q ↗ | Q1 FY2022 Mar 31, 2022 10-Q ↗ | Q4 FY2021 Dec 31, 2021 10-K ↗ | Q3 FY2021 Oct 31, 2021 10-Q ↗ | Q2 FY2021 Jan 31, 2022 10-Q ↗ | Q1 FY2021 Oct 31, 2021 10-Q ↗ | Q4 FY2020 Dec 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | — | — | $40.10M | — | $1.70M | — | — | — | $2.67M | — | — | — | — | — |
| Depreciation Expense (USD) | — | — | — | — | $3.98K | — | — | — | $6.95K | — | — | — | — | — |
| Net Income, GAAP (USD) | — | — | — | — | $-2.41M | — | — | — | $222.59K | — | — | $-1.19K | $-45.59K | — |
| Operating Cash Flow (USD) | — | — | — | — | $-469.91K | — | — | — | $-252.20K | — | — | — | — | — |
Secondary lens
Benchmark Lens
Compare EUDA against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare EUDA against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for EUDA
Return on Common Equity (%) is in the top quartile
Operating Margin (%) is in the bottom quartile
Profit Margin (%) is in the bottom quartile
Percentile Rankings
How EUDA compares to all companies
Peer Comparison
EUDA vs similar peers
Compare EUDA with peers
Stack EUDA against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 6 years · 14 quarters